Gwendolyn Wrenn Baxter

Array ( [id] => 7461324 [patent_doc_number] => 20040197838 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-07 [patent_title] => 'Phosphorylated histone h2b as apoptosis marker' [patent_app_type] => new [patent_app_number] => 10/485422 [patent_app_country] => US [patent_app_date] => 2004-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 10092 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20040197838.pdf [firstpage_image] =>[orig_patent_app_number] => 10485422 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7285856 [patent_doc_number] => 20040146514 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-29 [patent_title] => 'Cancer therapy using multiple antibodies from different species directed against the tumor3' [patent_app_type] => new [patent_app_number] => 10/759828 [patent_app_country] => US [patent_app_date] => 2004-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4089 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0146/20040146514.pdf [firstpage_image] =>[orig_patent_app_number] => 10759828 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7423134 [patent_doc_number] => 20040265310 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-30 [patent_title] => 'Novel prostate-restricted gene expressed in prostate cancer' [patent_app_type] => new [patent_app_number] => 10/759803 [patent_app_country] => US [patent_app_date] => 2004-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 25198 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0265/20040265310.pdf [firstpage_image] =>[orig_patent_app_number] => 10759803 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7326945 [patent_doc_number] => 20040253242 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-16 [patent_title] => 'Rationally designed antibodies' [patent_app_type] => new [patent_app_number] => 10/737290 [patent_app_country] => US [patent_app_date] => 2003-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 59 [patent_figures_cnt] => 59 [patent_no_of_words] => 32149 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0253/20040253242.pdf [firstpage_image] =>[orig_patent_app_number] => 10737290 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7406070 [patent_doc_number] => 20040175825 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-09 [patent_title] => 'Monoclonal antibody binding to mt4-mmp catalytic domain' [patent_app_type] => new [patent_app_number] => 10/480464 [patent_app_country] => US [patent_app_date] => 2003-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 19228 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20040175825.pdf [firstpage_image] =>[orig_patent_app_number] => 10480464 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7285844 [patent_doc_number] => 20040146507 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-29 [patent_title] => 'Antibody mutants' [patent_app_type] => new [patent_app_number] => 10/727737 [patent_app_country] => US [patent_app_date] => 2003-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 28171 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0146/20040146507.pdf [firstpage_image] =>[orig_patent_app_number] => 10727737 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7383581 [patent_doc_number] => 20040180035 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-16 [patent_title] => 'IL-15 immunoconjugates and uses thereof' [patent_app_type] => new [patent_app_number] => 10/714165 [patent_app_country] => US [patent_app_date] => 2003-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11539 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0180/20040180035.pdf [firstpage_image] =>[orig_patent_app_number] => 10714165 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 457038 [patent_doc_number] => 07244832 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-07-17 [patent_title] => 'Humanised antibodies' [patent_app_type] => utility [patent_app_number] => 10/703963 [patent_app_country] => US [patent_app_date] => 2003-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 19 [patent_no_of_words] => 16447 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 134 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/244/07244832.pdf [firstpage_image] =>[orig_patent_app_number] => 10703963 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 435795 [patent_doc_number] => 07262050 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-08-28 [patent_title] => 'Humanised antibodies' [patent_app_type] => utility [patent_app_number] => 10/703344 [patent_app_country] => US [patent_app_date] => 2003-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 19 [patent_no_of_words] => 16452 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 135 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/262/07262050.pdf [firstpage_image] =>[orig_patent_app_number] => 10703344 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 456354 [patent_doc_number] => 07244615 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-07-17 [patent_title] => 'Humanized antibodies' [patent_app_type] => utility [patent_app_number] => 10/704071 [patent_app_country] => US [patent_app_date] => 2003-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 19 [patent_no_of_words] => 16472 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 313 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/244/07244615.pdf [firstpage_image] =>[orig_patent_app_number] => 10704071 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7216378 [patent_doc_number] => 20040071693 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-15 [patent_title] => 'Humanised antibodies' [patent_app_type] => new [patent_app_number] => 10/704352 [patent_app_country] => US [patent_app_date] => 2003-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 16477 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 129 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0071/20040071693.pdf [firstpage_image] =>[orig_patent_app_number] => 10704352 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7220730 [patent_doc_number] => 20040072271 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-15 [patent_title] => 'Target specific screens and their use for discovering small organic molecular pharmacophores' [patent_app_type] => new [patent_app_number] => 10/681669 [patent_app_country] => US [patent_app_date] => 2003-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 50937 [patent_no_of_claims] => 75 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0072/20040072271.pdf [firstpage_image] =>[orig_patent_app_number] => 10681669 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7348283 [patent_doc_number] => 20040248218 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-09 [patent_title] => 'Gene SCC-112 and diagnostic and therapeutic uses thereof' [patent_app_type] => new [patent_app_number] => 10/679580 [patent_app_country] => US [patent_app_date] => 2003-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 18172 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 26 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0248/20040248218.pdf [firstpage_image] =>[orig_patent_app_number] => 10679580 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7369337 [patent_doc_number] => 20040092724 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-13 [patent_title] => 'Mucin' [patent_app_type] => new [patent_app_number] => 10/343253 [patent_app_country] => US [patent_app_date] => 2003-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 16768 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20040092724.pdf [firstpage_image] =>[orig_patent_app_number] => 10343253 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7311070 [patent_doc_number] => 20040143101 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-22 [patent_title] => 'Immunoglobulin construct containing anti-mucin variable domain sequences for eliciting an anti-idiotype anti-tumor response' [patent_app_type] => new [patent_app_number] => 10/469125 [patent_app_country] => US [patent_app_date] => 2003-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 19909 [patent_no_of_claims] => 96 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20040143101.pdf [firstpage_image] =>[orig_patent_app_number] => 10469125 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 506399 [patent_doc_number] => 07202343 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-04-10 [patent_title] => 'Antibodies directed to monocyte chemo-attractant protein-1 (MCP-1) and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/644277 [patent_app_country] => US [patent_app_date] => 2003-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 14 [patent_no_of_words] => 31909 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/202/07202343.pdf [firstpage_image] =>[orig_patent_app_number] => 10644277 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 390060 [patent_doc_number] => 07300655 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-11-27 [patent_title] => 'Alpha-fetoprotein Immu31 antibodies and fusion proteins and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 10/631722 [patent_app_country] => US [patent_app_date] => 2003-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 38263 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/300/07300655.pdf [firstpage_image] =>[orig_patent_app_number] => 10631722 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7397838 [patent_doc_number] => 20040018550 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-29 [patent_title] => 'Antibodies immunologically specific for a DNA repair endonuclease and methods of use thereof' [patent_app_type] => new [patent_app_number] => 10/629951 [patent_app_country] => US [patent_app_date] => 2003-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 44 [patent_no_of_words] => 25568 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 112 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0018/20040018550.pdf [firstpage_image] =>[orig_patent_app_number] => 10629951 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5219259 [patent_doc_number] => 20070160570 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-12 [patent_title] => 'Chimeric polypeptides containing chemokine domains' [patent_app_type] => utility [patent_app_number] => 10/614475 [patent_app_country] => US [patent_app_date] => 2003-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 14237 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20070160570.pdf [firstpage_image] =>[orig_patent_app_number] => 10614475 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7269434 [patent_doc_number] => 20040057952 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-25 [patent_title] => 'Antibodies to non-shed Muc1 and Muc16, and uses thereof' [patent_app_type] => new [patent_app_number] => 10/612090 [patent_app_country] => US [patent_app_date] => 2003-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 16398 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0057/20040057952.pdf [firstpage_image] =>[orig_patent_app_number] => 10612090 [rel_patent_id] =>[rel_patent_doc_number] =>)